These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7041941)

  • 1. Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
    Gasser AB; Depierre D; Mermillod B; Courvoisier B
    Br J Cancer; 1982 Mar; 45(3):477-81. PubMed ID: 7041941
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
    Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
    Radom S; Zulawski M; Golebiowska D
    Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
    [No Abstract]   [Full Text] [Related]  

  • 4. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
    Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
    Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary hydroxyproline excretion in patients with cancer.
    Guzzo CE; Pachas WN; Pinals RS; Krant MJ
    Cancer; 1969 Aug; 24(2):382-7. PubMed ID: 5796782
    [No Abstract]   [Full Text] [Related]  

  • 6. Total urinary and free serum hydroxyproline in metastatic bone disease.
    Gasser AB; Depierre D; Courvoisier B
    Br J Cancer; 1979 Mar; 39(3):280-3. PubMed ID: 465297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
    Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
    [No Abstract]   [Full Text] [Related]  

  • 8. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
    Ditzel J; Jordal R; Riskaer N
    Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
    Gasser AB; Jeannet C; Depierre D; Courvoisier B
    Schweiz Med Wochenschr; 1981 Feb; 111(8):246-51. PubMed ID: 7233140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyproline excretion in patients with breast cancer and response to treatment.
    Powles TJ; Leese CL; Bondy PK
    Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian rhythm of total urinary hydroxyproline excretion and 3-H hydroxyproline test.
    Radom S; Zulawski M; Dahlig E
    Clin Chim Acta; 1972 Jun; 39(1):277-8. PubMed ID: 4556834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB; Depierre D; Alberto P; Courvoisier B
    Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
    Frenay M; Namer M; Boublil JL; Khater R; Viot M; François E; Milano G
    Bull Cancer; 1988; 75(6):533-9. PubMed ID: 3416085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
    Lee CA; Lloyd HM
    Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urine hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in neoplastic diseases].
    Radom S; Zulawski M; Golebiowska D
    Nowotwory; 1971; 21(4):267-73. PubMed ID: 5138713
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastases.
    Basu TK; Donaldson D; Williams DC
    Oncology; 1974; 30(3):197-203. PubMed ID: 4459734
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
    Rinsho K; Aoyagi K
    Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER.
    KLEIN L; LAFFERTY FW; PEARSON OH; CURTISS PH
    Metabolism; 1964 Mar; 13():272-84. PubMed ID: 14127694
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
    Cuschieri A
    Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J; Jordal R; Riskoer N
    Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.